QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer

Clinical trial NCT06404736 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06404736
Sponsor: Fudan University
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Early Breast Cancer Neoadjuvant Therapy TNBC, Triple Negative Breast Cancer

Start date: 2024-05-07
Primary completion: 2025-11-07
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.